Information Journal Paper
APA:
Copy. (2017). Study design of an expanded access protocol of cpx-351 (cytarabine: daunorubicin) liposome injection in patients 60-75 years of age with secondary acute myeloid leukemia. BIOL BLOOD MARROW TRANSPLANT, 23(3), 249-250. SID. https://sid.ir/paper/726496/en
Vancouver:
Copy. Study design of an expanded access protocol of cpx-351 (cytarabine: daunorubicin) liposome injection in patients 60-75 years of age with secondary acute myeloid leukemia. BIOL BLOOD MARROW TRANSPLANT[Internet]. 2017;23(3):249-250. Available from: https://sid.ir/paper/726496/en
IEEE:
Copy, “Study design of an expanded access protocol of cpx-351 (cytarabine: daunorubicin) liposome injection in patients 60-75 years of age with secondary acute myeloid leukemia,” BIOL BLOOD MARROW TRANSPLANT, vol. 23, no. 3, pp. 249–250, 2017, [Online]. Available: https://sid.ir/paper/726496/en